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Abstract 
 
A paper-based lateral flow immunoassay whose photoluminescent properties can be 
modulated upon protein recognition via the photoluminescence quenching capabilities of 
graphene oxide (GO) is reported. The assay is intended for the detection of a model protein in 
human serum, that is, human immunoglobulin G, with the aim to demonstrate a virtually 
universal protein detection platform. Once the sample is added in the strip, the analyte is 
selectively captured by antibody-decorated SiO2 beads (Ab-SiO2) onto the conjugate pad and 
the sample flows by capillarity throughout the strip until reaching the test line, where a 
sandwich-like immunocomplex takes place due to the presence of antibody-functionalized 
QDs (Ab-QDs) onto the test line. Eventually, GO is added as a revealing agent and the 
photoluminescence of those sites protected by the complex Ab-SiO2/Antigen/Ab-QDs will not 
be quenched, whereas those photoluminescent sites directly exposed are expected to be 
quenched by GO, including the control line, made of bare QDs, reporting that the assay 
occurred successfully. Hence, the photoluminescence of the test line is modulated by the 
formation of sandwich-like immunocomplexes. The proposed device achieves a limit of 
detection (LOD) of 1.35 ng mL-1 in standard buffer, which is lower when compared with 
conventional lateral flow technology reported by gold nanoparticles, including other 
amplification strategies. Moreover, the resulting device was proven useful in human serum 
analysis, achieving a LOD of 6.30 ng mL-1 in this complex matrix. This low-cost disposable 
and easy-to-use device will prove valuable for portable and automated diagnostics 
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applications, and can be easily transferred to other analytes such as clinically relevant protein 
biomarkers. 
 
1. Introduction 
Lateral flow (LF) represents a powerful technique with high relevance in biosensing as it 
achieves the requirements needed for biosensor devices, including low cost, small amount of 
the sample, robustness and stability.  
Taking into account that in lateral flow strips the samples are driven by capillary forces, 
lateral flow strips are generally built with four parts, (i) the sample pad in which the sample is 
added in the strip; (ii) the conjugate pad, where specific antibodies targeting the analyte are 
conjugated with nanoparticles (most commonly gold nanoparticles); the detection pad that 
includes two different lines where the main immunoreactions take place, that is to say the 
control and test line. The test line is typically printed with antibodies targeting the analyte, 
while the control line is printed with other antibodies that capture the antibody that is tagged 
with an optically active material and comes from the conjugate pad. (iv) The absorbent pad, 
which operates as the pump of the system. Thus, after adding the sample, the labeled 
antibodies of the conjugate pad flow throughout the detection pad until they reach the test 
line , where a sandwich immunocomplex is performed provided the analyte is present in the 
sample, giving a signal depending of the analyte concentration. On the other hand, as 
mentioned above, the antibodies coming from the conjugate pad are always captured onto the 
control line to report that the analysis has been carried out correctly. Consequently, this 
technology can perform fast measurements and does not need qualified staff to be 
manipulated. (Posthuma-Trumpie et al., 2009; Quesada-González and Merkoçi, 2015; Sajid et 
al., 2015) However, LF has some drawbacks, for example at low concentrations of analyte 
this technology may present problems in terms of sensitivity. Furthermore, its membrane can 
saturate at high concentrations of the analyte and false negatives may appear as the membrane 
can be obstructed by different compounds presents in the analysed matrix and provoke 
unspecific absorptions. In this work, we strive to further LF technology by tackling the 
drawback of this technique related to its sensitivity.  
 
There is a high demand for the rapid and low-cost determination of proteins, (Fredriksson et 
al., 2002; Vollmer et al., 2002) particularly for medical applications. In this context, the most 
widely used tests are based on colorimetric procedures in which proteins react to produce 
colorimetric complexes, but nowadays other methods such as fluorimetry, (Xue et al., 2012; 
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Zhang et al., 2012) chemiluminescence (Roda and Guardigli, 2012) and spectrophotometry 
(Boja and Rodriguez, 2012) are being implemented for protein detection. These techniques 
represent an improvement in terms of sensitivity and selectivity in comparison with classical 
methods, such as colorimetric assays. In particular, we focus on photoluminescence 
measurements for the detection of a model protein, that is human immunoglobulin G. 
Photoluminescence has great advantages, (Wang and Ni, 2014; Yi et al., 2013) including a 
great sensitivity and excellent specificity, given that the devices intended for 
photoluminescence measurement are highly specific and less susceptible to interferences as 
few materials can absorb and emit light. Furthermore, this technique is simply to perform and 
is fast to measure. 
 
Our research team possesses experience in the usage of photoluminescent techniques and 
lateral technology flow-based devices.(Gravagnuolo et al., 2015; Zor et al., 2015) In a 
previous work, our team reported a photoluminescent LF for the detection of Escherichia coli 
(E. coli) using graphene oxide (GO) as a pathogen-revaling agent (Morales-Narváez et al., 
2015). In that work, E coli was employed as a spacer avoiding non-radiative energy transfer 
between photoexcited quantum dots (decorated with anti-E. coli antibodies and printed on the 
test line) and GO, which is known to be an excellent quencher of quantum dots.(Morales-
Narváez et al., 2012) Importantly, using graphene related materials, non-radiative energy 
transfer is observable up to ~30 nm.(Gaudreau et al., 2013) In this regard, bacteria is an 
excellent spacer facilitating the successful operation of the previously reported LF,(Morales-
Narváez et al., 2013) whereas this LF configuration is not applicable to protein detection since 
proteins are nanoscaled analytes (around 10 nm). Hence, in this research we engineered a new 
LF configuration and sought to achieve a highly sensitive photoluminescent lateral flow 
device for protein detection. 
 
The proposed biosensor consist in a paper-based strip, this approach combines anti-human 
immunoglobulin G (IgG) antibodies with quantum dots nanocrystals (CdSe@ZnS) as a highly 
specific photoluminescence probe (Ab-QDs) onto the test line and bare QDs printed onto the 
control line. Aiming at designing an integrated device, we also employ SiO2 beads 
functionalized with anti-human IgG antibodies (Ab-SiO2) in the respective conjugated pad. 
Importantly, these SiO2 beads are able to operate as a powerful spacer between photoexcited 
QDs and GO, avoiding non-radiative energy transfer as their diameter is greater than the 
nanoscale (300 – 600 nm). Once the sample is added in the strip, the analyte is selectively 
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captured by the Ab-SiO2 beads onto the conjugate pad and the sample flows by capillarity 
throughout the strip until reaching the test line, where a sandwich-like immunocomplex takes 
place due to the presence of Ab-QDs onto the test line. Eventually, GO is added as a revealing 
agent and the photoluminescence of those sites protected by the complex Ab-
SiO2/Antigen/Ab-QDs will not be quenched, whereas those photoluminescent sites directly 
exposed are expected to be quenched by GO, including the control line reporting that the 
assay occurred successfully. Hence, the photoluminescence of the test line is modulated by 
the formation of sandwich-like immunocomplexes (see Figure 1).  
 
2. Results and discussion 
 
As the assay depends on photoluminescent signals, we firstly optimized the concentration of 
the involved QDs. To this end, a strong photoluminescent signal hindering saturation of the 
LF reader should be chosen, whereas weak photoluminescent signals should be avoided. 
Consequently, as depicted in Figure S1, we printed different QD concentrations (from 4 to 11 
nM) onto various strips and measured their intensities utilizing a lateral flow reader 
(excitation wavelength of 365 nm, emission filter centered at 670 nm). Through these 
experiments we determined that 8 nM was an optimal concentration of this reagent as it 
displays a strong intensity of up to 75% of the dynamic range of the LF reader, thus avoiding 
saturation. 
We then explored different concentrations of GO so as to reach the maximum quenching of 
QDs in terms of the ratio initial intensity (before GO) / final intensity (after GO). To this end, 
different water-based suspensions of GO were directly added in the sample pad of several 
strips printed with QDs concentrated at 8 nM. Among several concentrations of GO, ranging 
from 70 to 120 µg mL-1, a GO concentration of 90 µg mL-1 was picked to yield a maximum 
quenching efficiency around 85% in both lines, test and control line, avoiding saturation of 
the flow due to a saturation of GO in the strip as it occurs with higher GO concentrations (see 
Figure S2). It is worth mentioning that according to the manufacturer’s characterization, the 
GO monolayer we are employing has an average lateral size of 500 nm and a carbon / oxygen 
ratio around 1. 
    In order to optimize the spacer agent avoiding highly efficient non-radiative energy transfer, 
we also investigated two sizes of SiO2 beads utilized as spacers between photoexcited QDs 
and GO, including monodispersed beads of 300 and 650 nm respectively (see Figure S3). To 
this end, SiO2 beads were previously conjugated to anti human IgG antibodies and embedded 
into the conjugation pad as described in the experimental section. We carried out our LF 
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approach using a standard buffer as a matrix, from now and the termed as immunobuffer, that 
is a mixture of phosphate-buffered saline 0.01M, bovine serum albumin 1% w/v, and Tween 
20 0.5%, and different concentrations of the analyte, ranging from 65 to 1000 ng mL-1. Blank 
samples were also analyzed. Figure S4 shows the overall sensitivity achieved by these assays, 
showing that the usage of SiO2 beads of 650 nm facilitates a better sensitivity in the assay 
probably due to its better efficiency as a bigger spacer that simultaneously amplifies the 
protected area that will not be quenched by GO.  
 
Figure S5 shows the relationship between the analyte concentration and the quenching effect 
in the proposed LF approach, where the highest concentrations of the analyte trigger the 
strongest photoluminescent signals, as quenching is avoided due to the operational principle 
of this biosensing approach. Hence, the quenching of the test line; QTL, defined as the final 
intensity of the test line divided by the initial intensity of the test line, has maximum values 
around 0.8 units, whereas the quenching of the control line; QCL, similarly defined as QTL, 
remains constant with values of less than 0.2 units. On the contrary, the lowest concentrations 
of the analyte give rise to highly efficient non-radiative energy transfer since SiO2 beads are 
scarcely present and thus GO is able to interact directly with the photoluminescent probes, 
mainly by physical adsorption forces, pi-pi stacking interactions and hydrogen bonding forces 
that can occur between GO and biomolecules such as proteins (Morales-Narváez et al., 2013). 
Consequently, the QTL values tend to approximate to those values of the QCL (see Figure 3A) 
In order to confirm the operational principle of the proposed LF strip, we investigated its 
different components via scanning electron microscopy (SEM). The SEM micrographs in 
Figure 2 reveal how SiO2 beads are efficiently anchored onto the test line (Figure 2A) and 
absent onto the control line (Figure 2B) due to the highly specific aforementioned 
immunoreaction. Panels B and D in Figure 2 display GO-coated LF strips, confirming that 
GO is able to flow throughout the strip and interact with the control and test line. 
 
 
Figure 3B displays a normalization in terms of the QTL/QCL ratio and the limit of detection 
(LOD) was calculated using this ratio in the analyzed blank sample plus 3 times its standard 
deviation. The LOD was determined to be c.a. 3.64 ng mL-1 (Figure S6A). At this point, this 
LF approach starts becoming advantageous in terms of LOD when compared with other LF 
approaches targeting IgG as it can be observed in Table 1.  However, we sought to improve 
the LOD of the LF approach even further. To this end, we replaced the capture polyclonal 
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antibody of the test line by a monoclonal antibody. It is well- known that monoclonal 
antibodies are able to improve both, sensitivity and specificity in immunoassays.(Deguchi et 
al., 2009) Hence, we tested this new configuration following the methods detailed in the 
experimental section and found that the usage of such a monoclonal antibody benefited the 
LOD of the LF approach. Figure 3C-D depicts the overall biosensing performance of this new 
configuration exhibiting a LOD of c.a. 1.35 ng mL-1, obtaining a significant improvement in 
the system sensitivity compared with the conventional methods.   Figure S6B displays the 
corresponding calibration curve.  
 
Moreover, in order to prove that this approach can be applied in real sample analyses, the 
resulting LF strip was also employed in human serum analysis. We employed human 
immunoglobulin (IgG/IgM/IgE)-depleted serum as a complex matrix that we spiked with 
different concentrations of IgG, ranging from 1000 ng mL-1 until 16 ng mL-1. Blank samples 
of this matrix were also analyzed. The prepared solutions can be directly added in the strip, 
though a washing step is necessary in order to remove possible interferences contained in 
such a complex matrix. This washing process was performed by adding 100 µL of 
immunobuffer once the sample is dried in the strip. After performing a calibration curve, the 
limit of detection this approach in human serum was 6.30 ng mL-1, calculated using the 
aforementioned definition of LOD. It is obvious that the matrix effect affects the overall 
analytical performance; however, this effect is well known in immunoassays, (Morales-
Narváez et al., 2014) and these experiments demonstrate the high sensitivity and selectivity of 
the proposed lateral flow approach even in a complex matrix.  
 
3. Conclusion 
A novel design based on lateral flow technology in combination with quantum dots and the 
usage of graphene oxide as revealing agent for specific, selective and highly sensitive protein 
detection  has been explored.  The overall analytical performance of the system was 
successfully explored in different matrices, including standard buffer and human serum, 
showing an advantageous limit of detection of 1.35 ng mL-1 and 6.30 ng mL-1, respectively. In 
comparison with other lateral flow immunoassays targeting human IgG, the developed 
biosensor presents excellent results in terms of LOD and its adequate behavior in human 
serum analysis proves that it can be a valuable tool in real sample analysis. 
Besides, LFA is a versatile and easy adaptable technique. Each component of the system can 
be easily modified with the aim of adapting the assay to a different target, obtaining the 
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possibility of a multidetection platform. The good point of paper-based diagnostics is that 
there are suitable for large scale production, making them a very cheap and efficient 
technology. This result could open the way to the use this LF in more diagnostics applications, 
especially in a medical or laboratory context, due to the lower limit of quantification obtained 
and improvement of the actual techniques for immunoglobulins detection with lateral flow.  
 
4. Experimental Section  
4.1 Reagents and materials 
Streptavidin-Quantum dots 655 were purchased from Life Technologies (Eugene, OR, USA). 
Anti human IgG (whole molecule, I1886), Human immunoglobulin depleted serum was 
purchased from Celprogen (Torrance,CA, USA) , IgG (I4506), PBS tablets and Tween 20 
were purchased from Sigma Aldrich (Madrid, Spain). Polyclonal antihuman IgG antibody 
conjugated with biotin (ab6869) and monoclonal Antihuman IgG antibody (ab99759) was 
pu0rchased form Abcam (Cambridge, UK). SiO2 beads were purchased from Microparticles 
GmbH (Berlin, Germany). Graphene oxide was purchased from Angstron Materials (Dayton, 
OH, USA), bovine serum albumin, laminated cards (HF000MC100), nitrocellulose 
membranes (SHF1800425), sample and adsorbent pads (CFSP001700) were purchased from 
Millipore (Billerica, MA, USA). 
An ESEQuant lateral flow reader from Qiagen GmbH (Stockach, Germany) was used to 
perform measurements on the LF strips. Biospot Bt-500 reagent dispersing system from 
Biofluidix (Freiburg, Germany). TS-100 thermoshaker from Biosan (Riga, Latvia) was 
utilized to perform the conjugation of QDs with antibodies. JP Selecta 2000210 oven from JP 
selecta (Barcelona, Spain) was used to dry lateral flow strips. SEM analysis was performed 
using FEI Magellan (Hillsboro, Oregon, USA). 
 
2.1. Lateral flow strip preparation 
Conjugation of QDs with antibodies. Biotinylated antibodies were easily conjugated with 
streptavidin-QDs. Streptavidin-QDs and biotinylated anti-IgG, were mixed at final 
concentrations of 8nM (QDs) and 300 µg mL-1 (anti-IgG), respectively, using a 
thermosshaker set at 600 rpm and 4 °C for two hours. This conjugation was carried out in 
immunobuffer (that is, PBS + 1% BSA + Tween 20 0.5%). 
The conjugate pad was impregnated with antibody-decorated SiO2 beads with anti-IgG. 
Firstly, the conjugate is created by applying successive washing steps in a suspension the SiO2 
beads. To do that, 75 µL of the stock suspension of the beads was added in 925 μL of PBS 
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buffer. The suspension was then shaken at 650 rpm during 10 minutes and centrifuged at 5000 
rpm for 1min in order to precipitate the particles, and facilitate the subsequent removal of the 
supernatant. To complete the particle washing, the process is repeated three times using PBS, 
once using PBS supplemented with Tween 20 at 0.05% (PBST) and once with Immunobuffer. 
Next, 1 mL of anti-human IgG concentrated at 500 µg mL-1 in Immunobuffer is added in the 
pellet of the previously washed particles and this suspension was shaken at 600 rpm for 2h at 
4ºC. After this process is finished, a glass fiber strip was soaked by drop casting with the Ab-
SiO2 beads conjugate suspension, and dried at room temperature overnight.  
The fabrication of the strips is divided in three parts, (i) assemblage of the detection pad onto 
the laminated card and and printing of the test and control line onto the detection pad using 
the Isoflow reagent dispensing system. Antibody-decorated QDs are printed onto the test line, 
while bare QDs are printed onto the control line and these laminated cards are stored 
overnight in the fridge (at 8 °C). (ii) Blocking of the detection pad by adding 5 mL of 
immunobuffer in the laminated card and storing the strip for 15 min in the fridge. Next, the 
strip is dried in an oven at 37ºC for 90 min. (iii) Sample and absorbent pads are washed and 
assembled onto the laminated card. This washing procedure involves a washing procedure 
through ultrapure water, PBST and immunobuffer and a drying process overnight at room 
temperature. After that the sample and absorbent pads can be assembled onto the laminated 
card along with the conjugate pad. We normally manufacture strips that are 6 mm with size. 
 
2.2. Overall measurement procedure 
Human IgG protein was analyzed at different concentrations ranging from 65 ng mL-1 to 1 µg 
mL-1 in immunobuffer. The starting intensity of the lateral flow strip was determined using 
the ESEQuant lateral flow reader. After adding 100 µL of the sample onto the sample pad, 15 
minutes are given for the sample to flow throughout the strip and arrive in the absorbent pad, 
which is the last part of strip. Next, the strip is dried using an oven at 37ºC for 1 hour, and 100 
µL of an aqueous dispersion of GO concentrated at 90 µg mL-1 (see Figure S) was added in 
the sample pad as a revealing agent using the same aforementioned drying procedure (37 ºC 
for 1 hour). Eventually, the strips are measured using the lateral flow reader. The assays 
implying human serum analysis may require a washing step before GO addition. To this end, 
100 µL of immunobuffer were added in the sample pad in order to eliminate impurities and 
minimize the matrix effect. 
 
 
Supporting Information  
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Figure 1. Scheme of the developed lateral flow  
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Figure 2. SEM micrographs of the lateral flow strip. Test line before adding GO (A) and after 
GO addition (B). Control line before adding GO (C) and after GO addition (D). 
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Figure 3. Representation of measurements in stardard buffer for test and control line of each 
concentration of IgG (a) , the bars represents % of quenching ( coefficient of final intensity 
and initial), (b) normalized values  (QTL/QCL) and (c) same experiment using monoclonal 
antibody, (d) normalized values. 
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Figure 4. Results of measurements in human serum. (A) Comparison of TL and CL of each 
strip (B) normalized values 
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Table 1. Comparison of LOD for IgG detection.  
 
 
LF strategy Range LOD Technique REF 
Conventional LF 5-500 ng mL-1 8-12 ng/mL Colorimetric Lab Chip, 
2014,14, 
4406-
4414Lab 
Chip, 
2015,15, 399-
405 
LF with wax pillars 
onto the detection 
pad 
5-500 ng mL-1 6,6 ng/mL Colorimetric Lab Chip, 
2014,14, 
4406-4414 
gold nanoparticles 
loaded with 
enzymes 
2-10 ng mL-1 2 ng mL-1 Colorimetric Biosensors 
and 
Bioelectronics 
40 (2013) 
412–416 
LF QDs-GO (this 
work) 
1-20 ng mL-1 1,35 ng mL-1 Fluorescence - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
15 
 
Supporting Information  
 
 
Photoluminescent lateral flow based on non-radiative energy transfer for protein 
detection in human serum 
 
Alejandro Zamora-Gálveza, Eden Morales-Narváeza,b, Javier Romeroa, and Arben 
Merkoçia,c* 
 
a ICN2 Nanobioelectronics & Biosensors Group, Institut Català de Nanociència i 
Nanotecnologia, Campus UAB, Bellaterra, Barcelona 08193, Spain. 
 
b Biophotonic Nanosensors Laboratory, Centro de Investigaciones en Óptica, A. C. Loma del 
Bosque 115, Colonia Lomas del Campestre, Leon 37150, Guanajuato, Mexico. 
 
c ICREA Institució Catalana de Recerca i Estudis Avançats, Barcelona 08010, Spain 
 
* arben.merkoci@icn2.cat 
 
Figure S1. Optimization of QDs concentration. 
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Figure S2. Optimization of graphene oxide concentration. 
 
Figure S3. SEM micrographs of SiO2 NPs of (A) 300nm and (B) 650 nm. 
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Figure S4. Optimization of SiO2 NPs size, a) 300 nm, b) 650nm and c) comparative graphic 
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Figure S5. Profile of the photoluminescent intensity of the explored lateral flow strips at 
different concentrations of IgG. 
 
 
Figure S6. Calibration curve of IgG measurements with polyclonal (a) and monoclonal (b) 
antibody and in human serum (c). 
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